Nordea Investment Management AB Acquires 31 Shares of Chemed Corporation $CHE

Nordea Investment Management AB grew its holdings in Chemed Corporation (NYSE:CHE) by 0.2% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 13,668 shares of the company’s stock after buying an additional 31 shares during the quarter. Nordea Investment Management AB’s holdings in Chemed were worth $6,583,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. Renasant Bank raised its position in shares of Chemed by 2.3% in the 1st quarter. Renasant Bank now owns 815 shares of the company’s stock valued at $501,000 after buying an additional 18 shares in the last quarter. Cim LLC increased its stake in shares of Chemed by 1.0% in the first quarter. Cim LLC now owns 2,029 shares of the company’s stock worth $1,248,000 after buying an additional 21 shares during the period. First Horizon Advisors Inc. raised its position in shares of Chemed by 16.1% in the 1st quarter. First Horizon Advisors Inc. now owns 173 shares of the company’s stock worth $107,000 after purchasing an additional 24 shares during the last quarter. Cynosure Group LLC grew its stake in shares of Chemed by 4.3% during the 1st quarter. Cynosure Group LLC now owns 581 shares of the company’s stock valued at $358,000 after acquiring an additional 24 shares during the period. Finally, Brogan Financial Inc. raised its holdings in shares of Chemed by 7.3% during the 1st quarter. Brogan Financial Inc. now owns 426 shares of the company’s stock worth $262,000 after acquiring an additional 29 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Trading Up 1.0%

NYSE:CHE opened at $444.88 on Tuesday. The firm has a fifty day simple moving average of $449.12 and a two-hundred day simple moving average of $501.78. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The stock has a market capitalization of $6.48 billion, a price-to-earnings ratio of 22.87, a PEG ratio of 2.56 and a beta of 0.43.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by ($1.75). The company had revenue of $618.80 million during the quarter, compared to the consensus estimate of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.The business’s revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the firm posted $5.47 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities analysts predict that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 11th were paid a dividend of $0.60 per share. The ex-dividend date was Monday, August 11th. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.50. Chemed’s dividend payout ratio (DPR) is 12.34%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CHE. Bank of America decreased their price target on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Jefferies Financial Group raised Chemed from a “hold” rating to a “buy” rating and lifted their price objective for the company from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a report on Saturday, July 5th. Oppenheimer dropped their price target on shares of Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a research note on Thursday, July 31st. Finally, Royal Bank Of Canada dropped their price objective on shares of Chemed from $640.00 to $589.00 and set an “outperform” rating for the company in a report on Thursday, July 31st. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Chemed has an average rating of “Moderate Buy” and an average target price of $578.50.

Insider Buying and Selling at Chemed

In related news, Director George J. Walsh III acquired 200 shares of the firm’s stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average cost of $417.10 per share, with a total value of $83,420.00. Following the transaction, the director directly owned 3,523 shares of the company’s stock, valued at $1,469,443.30. This trade represents a 6.02% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the firm’s stock in a transaction on Monday, August 4th. The shares were sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,162 shares of company stock valued at $5,677,511. 3.29% of the stock is owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.